_visions & bets

Defence Therapeutics is a Canadian biotechnology company based in Vancouver. The company develops biological and biosimilar antibody-based therapeutic drugs and vaccines against cancer and infectious diseases.

Research is cost-intensive and the chances of success are rather low. Nevertheless, I have confidence in a positive development until 2030.

At EUR 1.02, the share price is currently close to its historic low. From its high of EUR 5.54 on September 10, 2021, the share price has continuously lost value. Betting on a positive development is risky and the prospects are very vague. In the event of successful product development, however, I assume a very high price increase in the thousands of percent range, otherwise the investment would have to be largely written off.

All in all, I am speculating on a price peak of over EUR 100 by 2030.

Pages: 1 2 3 4 5

Leave a Reply

Your email address will not be published. Required fields are marked *